Vacancy at Biocon for Packaging Engineer: Formulations

Vacancy at Biocon for Packaging Engineer: Formulations

Packaging Engineer – Formulations
 6 -10 years
 M. Pharm Pharmaceutics
 Job Description
Developing multifunctional, cost effective, eco-friendly packaging solutions to meet specific needs and requirements.

Working on devices i.e. auto-injector, Pens for Cartridges for US, EU & other major markets.

Development of change part for solid oral dosage form (blisters and strips) as primary & secondary packs for injectable products like Vial, Ampoule and PFS.

 Send Resumes  [email protected]

About Biocon:

Biocon, India’s largest biotech company is focused on delivering affordable innovation. Biocon’s key innovations include an indigenous recombinant human insulin based on proprietary fermentation technology, INSUGEN®, insulin analogue Glargine, BASALOG® and India’s first indigenously produced monoclonal antibody BioMAb-EGFR®, for head & neck cancer. INSUPen® is a next generation affordable insulin delivery device introduced in India by Biocon. Over the decades, Biocon has successfully evolved into an emerging global biopharma enterprise, serving its partners and customers in over 100 countries. Biocon has rapidly developed a robust novel and biosimilars pipeline, focusing on Diabetes, Oncology and auto-immune diseases, which has several molecules at different stages of the development cycle.

It has successfully developed and taken a range of novel biologics, biosimilars, differentiated small molecules and affordable recombinant human insulin and analogs from ‘Lab to Market’. Some of its key brands are INSUGEN®(rh-insulin), BASALOG® (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb(Itolizumab), a ‘first in class’ anti-CD6 monoclonal antibody. It has a rich pipeline of biosimilars and novel biologics at various stages of development including a high potential Insulin Tregopil.

For Pharma Jobs: Click here

For Online shopping offers : Click Here

Team Pharmacy Infoline


Team Pharmacy Infoline

Leave a Reply

Your email address will not be published. Required fields are marked *